LAM Therapeutics Closes $40M in Financing and Announces Two Clinical-Stage Programs in Rare Diseases and Cancer

Return to News >

Bringing the total raised for the current class of 4Catalyzer companies to a quarter-billion dollars

GUILFORD, Conn. –Feb. 2, 2016– LAM Therapeutics closed a $40 million financing to accelerate the development of therapeutics for the treatment of rare diseases and cancer. LAM Therapeutics is a 4Catalyzer company. 4Catalyzer is Connecticut’s premier biotechnology […]

2017-12-20T10:57:06+00:00 February 3rd, 2016|Categories: News|